Document Detail


Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
MedLine Citation:
PMID:  7572688     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries trial (PLAC-II) was initiated in 1987 and was the first double-blind, randomized clinical trial with progression of early extracranial carotid atherosclerosis as an outcome variable. We randomized 151 coronary patients to placebo or pravastatin and treated them for 3 years. B-mode ultrasound quantification of carotid artery intimal-medial thickness (IMT) was obtained at baseline and sequentially during this period. The primary outcome was the change in the mean of the maximum IMT measurements over time. Effects on individual carotid artery segments (common, bifurcation, internal carotid artery) and on clinical events were also investigated. During follow-up, plasma concentrations of total cholesterol were lower in pravastatin-treated patients compared with those of placebo-treated patients (4.81 vs 6.08 mmol/liter [186 vs 235 mg/dl]) as were concentrations of low density lipoprotein (LDL) cholesterol (3.10 vs 4.29 mmol/liter [120 vs 167 mg/dl]). Plasma concentrations of high density lipoprotein2 (HDL2) cholesterol were higher in pravastatin-treated patients than in placebo-treated patients (0.16 vs 0.14 mmol/liter [6.1 vs 5.5 mg/dl]). Active treatment resulted in a nonsignificant 12% reduction in progression of the mean-maximum IMT (from 0.068 mm/yr placebo to 0.059 mm/yr pravastatin) and a statistically significant 35% reduction in IMT progression in the common carotid (p = 0.03). Active treatment was also associated with a 60% reduction of nonfatal myocardial infarction plus death caused by coronary artery disease (p = 0.09), a 61% reduction of any fatal event plus any nonfatal myocardial infarction (p = 0.04), and an 80% reduction of fatal plus any nonfatal myocardial infarction (p = 0.03).
Authors:
R P Byington; C D Furberg; J R Crouse; M A Espeland; M G Bond
Related Documents :
2668448 - Coronary heart disease in south asians overseas: a review.
10559508 - Hmg coa reductase inhibitors are related to improved systemic endothelial function in c...
25231508 - Effect of spironolactone on diastolic function in hypertensive left ventricular hypertr...
11090258 - Association of lipoprotein(a), prostaglandin i(2)--synthesis stimulating plasma factor,...
7083538 - Mitral valve replacement after closed mitral commissurotomy.
3744948 - Hypoxia mediated binding of misonidazole in non-malignant tissue.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of cardiology     Volume:  76     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1995 Sep 
Date Detail:
Created Date:  1995-10-27     Completed Date:  1995-10-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  54C-59C     Citation Subset:  AIM; IM    
Affiliation:
Department of Public Health Sciences, Bowman Gray School of Medicine, Winston Salem, North Carolina 27157, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticholesteremic Agents / therapeutic use*
Arteriosclerosis / blood,  drug therapy*,  ultrasonography
Carotid Arteries / drug effects,  ultrasonography
Carotid Artery Diseases / blood,  drug therapy*,  ultrasonography
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Death, Sudden, Cardiac / prevention & control
Double-Blind Method
Female
Follow-Up Studies
Humans
Lipids / blood*
Male
Middle Aged
Myocardial Infarction / prevention & control
Pravastatin / therapeutic use*
Tunica Intima / drug effects,  ultrasonography
Chemical
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Lipids; 81093-37-0/Pravastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Unresolved issues in early trials of cholesterol lowering.
Next Document:  Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pr...